Characteristics of psychotic patients don't come to appointments;Taburculuk sonrasi tedaviye gelmeyen psikotik hastalarin özellikleri

Anadolu Psikiyatri Dergisi

Volumn 7, Issue 2, 2006, Pages 67-75

  Ünal, Süheyla ^a   Çakil, Gönül ^a   Elyas, Zeynep ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic psychotic disorders; Noncompliance; Out patient follow up

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC PATIENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MENTAL DISEASE; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT TRANSPORT; PSYCHOSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SCHIZOPHRENIA; SEX RATIO; SOCIAL ASPECT; TEAMWORK; TELEPHONE; UNSPECIFIED SIDE EFFECT;

EID: 33745317165     PISSN: 13026631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Mason C. Non-attendance at out-patient clinic: a case study. J Adv Nurs 1992; 17:554-560.
2. Nose M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003; 183:197-206.
3. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders. Reasons and remedies. CNS Drugs 1998; 9:457-471.
4. Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR. Prediction of compliance with outpatient referral among inpatients with schizophrenia and psychoactive substance use disorders. Arch Gen Psychiatry 1997; 54:706-712.
5. Bogin DL, Anish SS, Taub HA, Klein GE. The effects of a referral coordinator on compliance with psychiatric discharge plans. Hosp Community Psychiatry 1984; 35:702-706.
6. Solomon P, Davis J, Gordon B. Discharged state hospital patients' characteristics and use of aftercare: effect on community tenure. Am J Psychiatry 1984; 141:1566-1570.
7. Yegenoglu S, Wertheimer AL, Dubin WR. Demographical factors affecting patient compliance (adherence) to medications in an outpatient psychiatric clinic: a preliminary study. Fabad J Pharm Sci 2004; 28:77-84.
8. Agarwal MR, Sharma VK, Kishore Kumar KV, Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry 1998; 44:92-106.
9. Coodin S, Staley D, Cortens B, Desrochers R, McLandress S. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry 2004; 49:145-148.
10. Kampman O, Laippala P, Vaananen J, Koivisto E, Kiviniemi P, Kilkku N et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res 2002; 110:39-48.
11. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106:286-290.
12. Compton MT. Barriers to initial outpatient treatment engagement following first hospitalization for a first episode of nonaffective psychosis: a descriptive case series. J Psychiatr Pract 2005; 11:62-69.
13. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63:892-908.
14. Fleischhacker WW, Meise U, Gunther V, Kurz M. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand Suppl 1994; 382:11-15.
15. Weiden P, Mott T, Curcio N. Recognition and management of neuroleptic noncompliance: C Shriqui, H Nasrallah (eds), Contemporary Issues in the Treatment of Schizophrenia. Washington, DC., American Psychiatric Press, 1995, s.411-434.
16. Awad AG, Voruganti LNP, Heslegrave RJ. Assessment of the patient's subjective experiences in acute neuroleptic treatment: implications for compliance and outcome. Int Clin Psychopharmacol 1996; 11:55-60.
17. Perkins D. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63:1121-1128.
18. Weiden P, Aquila R, Standard J. Atypical antipsychotic drugs and long-term outcome in schizophrenia. J Clin Psychiatry 1996; 57:53-60.
19. Sheitman BB, Lee H, Strauss R, Lieberman JA. The evaluation and treatment of first-episode psychosis. Schizophr Bull 1997; 23:653-661.
20. Yildiz M, Yazici A, Ünal S, Aker T, Özgen G, Ekmekçi H ve ark. Şizofreninin ruhsal-toplumsal tedavisinde sosyal beceri egitimi - Belirtilerle baş etme ve ilaç tedavisi yaklaşiminin Türkiye'de çok merkezli bir uygulamasi. Turk Psikiyatri Derg 2002; 13:41-47.
21. Barron WM. Failed appointments: who misses them, why they are missed and what can be done. Primary Care 1980; 7:563-574.
22. Campbell B, Staley D, Matas M. Who misses appointments? An empirical analysis. Can J Psychiatry 1991; 36:223-225.
23. Mooney DK, Johnson RD. Rural mental health appointment adherence: implications for therapy. Community Ment Health J 1992; 28:135-139.
24. Killaspy H, Banerjee S, King M, Llyod M. Prospective controlled study of psychiatric outpatient non-attendance. Br J Psychiatry 2000; 176:160-165.
25. Homung WP, Klingberg S, Feldmann R, Schonauer K, Schulze Monking H. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand 1998; 97:213-219.
26. Lindström E, Bingefors K. Patient compliance with drug therapy in schizophrenia. Economic and Clinical Issues Pharmaco Economics 2000; 18:105-124.
27. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis 1996; 184:653-659.
28. Pyne JM, Bean D, Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. J Nerv Ment Dis 2001; 189:146-153.
29. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106: 286-290.
30. Philips M R. The transformation of China's mental health service. China J 1998; 39:1-36.
31. Blackwell B. The drug defaulter. Clin Pharmacol Ther 1972; 13:841-848.
32. Mantonakis J, Markidis M, Kontaxakis V, Liakos A. A scale for detection of negative attitudes towards medication among relatives of schizophrenic patients. Acta Psychiatr Scand 1985; 71:186-189.
33. Kruse GR, Rohland BM. Factors associated with attendance at a first appointment after discharge from a psychiatric hospital. Psychiatric Services 2002; 53:473-476.
34. Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand. 2000; 102:203-210.
35. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D et al. Attitudes toward anti-psychotic medication the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005; 62:717-724.
36. Kampman O. Commentary about "Review: over 25% of people with schizophrenia, psychoses, or severe mental disorders fail to adhere to treatment programmes". Evid Based Ment Health 2004; 7:40-4,1.
37. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002; 159:103-108.
38. Marder SR. Overview of partial compliance. J Clin Psychiatry 2003; 64(Suppl.16):3-9.